[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366606-105":59,"doc-detail-366606-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","combination-of-hydralazine-and-all-trans-retinoic-acid-targeting-breast-cancer-cells","Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells","","Breast cancer remains a leading cause of cancer-related mortality in women, and combination therapies can improve outcomes by lowering doses and reducing drug resistance. Hydralazine, an antihypertensive, may trigger epigenetic changes, while all-trans retinoic acid (ATRA), a vitamin A derivative, can modulate receptors and gene regulation. This work evaluates the biological effects of hydralazine and ATRA alone and together on breast cancer cells, including pathway and gene targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/combination-of-hydralazine-and-all-trans-retinoic-acid-targeting-breast-cancer-cells/366606/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/combination-of-hydralazine-and-all-trans-retinoic-acid-targeting-breast-cancer-cells/366606.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the study assess whether hydralazine and ATRA work synergistically?","Question",{"text":112,"@type":113},"Bioinformatics analysis evaluates pathway interactions, and laboratory experiments measure drug effects using IC50, isobologram testing, and wound healing assays.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What cell models are used in the experiments?",{"text":117,"@type":113},"MDA-MB-231 is used as the tumor cell line, and MCF10 is used as the normal cell line.",{"name":119,"@type":110,"acceptedAnswer":120},"What overall effect does the combination treatment have on cancer versus normal cells?",{"text":121,"@type":113},"The combination significantly reduces survival in cancer cells, while the impact on normal cells is not significant, supporting more selective anticancer activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366606,1790260264,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Yahyapour et al. BMC Cancer (2025) 25:1427 [https://doi.org/10.1186/s12885-025-14477-2](https://doi.org/10.1186/s12885-025-14477-2)  \nBMC Cancer  \nRESEARCH Open Access  \nCombination of hydralazine and all-trans retinoic acid targeting breast cancer cells  \nAmirhesan Yahyapour 1, Nahid Askari 1* and Mohammad Mehdi Yaghoobi 1  \nAbstract  \nBackground Breast cancer is one of the most common malignancies and causes of mortality in women. Combination therapies are one of the treatment approaches that contribute to better performance, reduced dosage, and drug resistance. Hydralazine is an antihypertensive drug, but it can induce epigenetic changes such as DNA methylation reversal in cancer cells. ATRA is a type of vitamin A, and its deficiency is associated with the progression of various diseases. It can bind to receptors and regulate genes to inhibit multiple types of cancers.  \nMethods According to bioinformatics studies, combining these two drugs can inhibit breast cancer cells. This study investigates various biological pathways, such as HIF-1, VEGF, and WNT, with the key genes of CCND1, VEGFA, VEGFA2, HIF1A, and HIF1A-AS. In the laboratory, MDA-MB-231, as a tumor cell line, and MCF10, as a normal cell line, were cultured, and the MTT assay was performed to obtain the IC50 of the drugs. Using these concentrations, isobologram and wound healing tests were performed. Gene expression was measured using real-time PCR.  \nResults Results showed that hydralazine alone stimulated cancer cell growth, potentially inducing breast cancer. ATRA reduced cell survival in both normal and cancer cells. However, the combination treatment exhibited differential effects, causing a significant reduction in survival in cancer cells while the impact on normal cells was not significant. Conclusions Hydralazine/ATRA combination inhibits cancer cell proliferation and their adaptation to hypoxia. These findings suggest a potential for new treatment targeting breast cancer cells with minimized side effects.  \nClinical trial registration Clinical trial number: “not applicable”.  \nKeywords Breast cancer, Hydralazine, All-trans retinoic acid (ATRA), Drug synergy, Cell proliferation  \nIntroduction  \nCancer is one of the leading causes of death worldwide and a complex disease caused by genetic mutations in cells during tumor growth. Conventional cancer treatments, such as chemotherapy, radiotherapy, or immunotherapy, although often effective, have significant drawbacks, including tumor resistance and considerable  \n*Correspondence: Nahid Askari[n.askari@kgut.ac.ir](n.askari@kgut.ac.ir)  \n1Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran  \nside effects, such as decreased appetite, nausea, weakness, and hair loss. To address these limitations and reduce the necessary drug dosage, targeted therapies are being explored, focusing on discovering innovative compounds. Dual drug compounds offer a promising strategy to overcome these negative aspects of current treatment options [1].  \nCancer drugs prevent tumor growth and metastasis by inhibiting cell proliferation, differentiation, and angiogenesis, as well as inducing programmed cell death. By targeting angiogenesis, they deprive tumors of the nutrients and oxygen necessary for their growth and spread. Despite their effectiveness, resistance to anti-angiogenic  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or","cbCaistLz32qWrX0","https://ap.wps.com/l/cbCaistLz32qWrX0","pdf",4347818,18,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusions\n# Clinical trial registration\n# Keywords\n# Introduction","[{\"question\":\"How does the study assess whether hydralazine and ATRA work synergistically?\",\"answer\":\"Bioinformatics analysis evaluates pathway interactions, and laboratory experiments measure drug effects using IC50, isobologram testing, and wound healing assays.\"},{\"question\":\"What cell models are used in the experiments?\",\"answer\":\"MDA-MB-231 is used as the tumor cell line, and MCF10 is used as the normal cell line.\"},{\"question\":\"What overall effect does the combination treatment have on cancer versus normal cells?\",\"answer\":\"The combination significantly reduces survival in cancer cells, while the impact on normal cells is not significant, supporting more selective anticancer activity.\"}]","Combination of hydralazine and all-trans retinoic acid targeting breast cancer cells | PDF",1790166396,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5470c8a6dd36fa4e542a73a9dc32005d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3a59a8de9e4cc4a30dfd61b90491d221.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c314f672bfba11deb8a167e3fea6c19d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e075ab1c4bec5cb5c4afb2d602e838f.webp",980,1306]